| | | |
Number of Shares Owned or
Controlled or Directed |
| |
Percentage of
|
| |
Percentage of
|
| |||||||||||||||||||||||||||
| | | |
Subordinate
Voting Shares |
| |
Multiple
Voting Shares |
| |
Subordinate
Voting Shares |
| |
Multiple
Voting Shares |
| |
Total
Shares |
| |
Total
Votes |
| ||||||||||||||||||
| Stephen Hurst | | | | | 0 | | | | | | 488,424.38(1) | | | | | | 0 | | | | | | 73.3% | | | | | | 0.1%(2) | | | | | | 12.0% | | |
| |
Name and Place of
Residence |
| | |
Position with
MindMed and Date First Appointed to the Board |
| | |
Principal Occupation
|
| | |
Number and
Percentage of Shares Beneficially Owned or Controlled(1) |
| |
| |
Jamon Alexander Rahn
Florida, USA |
| | |
Director and Chief Executive Officer
(February 27, 2020) |
| | | Chief Executive Officer of the Corporation (2021 – Present); Co-Chief Executive Officer of the Corporation (2020 – 2021); Chief Executive Officer of Upgraded Technologies Inc. (2016 – 2017); Operations Manager at Uber Technologies Inc. (2015 – 2016) | | | |
4,506,100
Subordinate Voting Shares
35,000
Multiple Voting Shares
(2%)
|
| |
| |
Miriam Halperin Wernli
Baar, Switzerland |
| | |
Director and President
(February 27, 2020) |
| | | Co-founder and Group Chief Executive Officer of Creso Pharma Ltd. (2016 – 2020); Vice President, Deputy Head Global Clinical Development, Global Head Business & Science Affairs of Actelion Pharmaceuticals (2007 – 2016) | | | |
450,000
Subordinate Voting Shares
(0.1%)
|
| |
| |
Stephen L. Hurst
Nevada, USA |
| | |
Director
(February 27, 2020) |
| | | Co-Chief Executive Officer of MindMed (2020 – 2021), Co-founder, Director, President& CEO of Savant HWP, Inc. (2009 – Present) | | | |
488,424.4
Multiple Voting Shares(1)
(12.0%)
|
| |
| |
Bruce Linton(2)(3)
Ontario, Canada |
| | |
Director
(February 27, 2020) |
| | | Director, Co-Chairman and former Chief Executive Officer of Martello Technologies Group Inc. (2007 – Present); Chief Executive Officer of Canopy Growth Corporation (2014 – 2019); Executive Chairman of Vireo Health International (November 2019 – June 2020); Executive Chairman of Gage Cannabis (November 2019 – Present); CEO and Chairman of the Board of Collective Growth Corporation (May 2020 to April 2021) | | | |
10,200,000
Subordinate Voting Shares(4)
(2.5%)
|
| |
| |
Perry Dellelce(2)(3)
Ontario, Canada |
| | |
Chairman of the Board and Director
(February 27, 2020)
|
| | | Managing Partner of Wildeboer Dellelce LLP (1993 – Present) | | | |
6,395,744
Subordinate Voting Shares(5)
(1.6%)
|
| |
| |
Name and Place of
Residence |
| | |
Position with
MindMed and Date First Appointed to the Board |
| | |
Principal Occupation
|
| | |
Number and
Percentage of Shares Beneficially Owned or Controlled(1) |
| |
| |
Brigid A. Makes(2)(3)
California, USA |
| | |
Director
(February 27, 2020) |
| | | Consultant (2017 – Present); Senior Vice President and Chief Financial Officer of Miramar Labs (2011 – 2017) Director and Chair of Audit Committee and the Nominating & Corporate Governance Committee of Aziyo Biologics (2020 – Present) | | | |
172
Multiple Voting Shares
(0.0%)
|
| |
| |
Name
|
| | |
Name & Jurisdiction of
Reporting Issuer |
| | |
Exchange
|
| | |
Position
|
| | |
From
|
| | |
To
|
| |
| |
Bruce Linton
|
| | |
Canopy Growth Corporation
All provinces and territories of Canada |
| | |
TSX,
NYSE |
| | |
Co-CEO
Chairman |
| | |
March 26, 2014
|
| | |
July 2, 2019
|
| |
|
Canopy Rivers Inc.
British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Prince Edward Island and Newfoundland |
| | |
TSX
|
| | |
Chairman
and Director |
| | |
September 17,
2018 |
| | |
July 2, 2019
|
| | |||||
|
Canopy Rivers Inc.
British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Prince Edward Island and Newfoundland |
| | |
TSXV
|
| | |
Director
|
| | |
August 25, 2012
|
| | |
November 28,
2016 |
| | |||||
|
The Limestone Boat Company
Limited (formerly LL One Inc.) British Columbia, Alberta and Ontario |
| | |
TSXV
|
| | |
Director
|
| | |
August 8, 2019
|
| | |
March 2, 2021
|
| | |||||
|
Vireo Health International,
Inc. British Columbia, Alberta and Ontario |
| | |
CSE
|
| | |
Executive
Chairman Director |
| | |
November 7, 2019
|
| | |
June 8, 2020
|
| | |||||
|
Gage Growth Corp.
British Columbia and Ontario |
| | |
CSE
|
| | |
Executive
Chairman |
| | |
April 2021
|
| | |
Present
|
| | |||||
|
Martello Technologies Group Inc.
British Columbia, Alberta and Ontario |
| | |
TSXV
|
| | |
Director
|
| | |
August 16, 2018
|
| | |
Present
|
| | |||||
| |
Perry Dellelce
|
| | |
Mount Logan Capital Inc.
British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, New Brunswick, Nova Scotia, Prince Edward Island and Newfoundland |
| | |
NEO
|
| | |
Director
|
| | |
October 19,
2018 |
| | |
Present
|
| |
|
Cricket Media Group Ltd.
Ceased Reporting |
| | |
TSXV
|
| | |
Director
|
| | |
June 20, 2011
|
| | |
May 18,
2016 |
| | |||||
|
Lendified Holdings Inc.
British Columbia, Alberta and Ontario |
| | |
TSXV
|
| | |
Director
|
| | |
March 10, 2020
|
| | |
Present
|
| |
|
Director
|
| |
Board
Meetings Attended |
| |
Audit
Committee Meetings Attended |
| |
Compensation,
Nomination and Governance Committee Meetings Attended |
|
| Jamon Alexander Rahn | | |
7 of 7
|
| |
N/A
|
| |
N/A
|
|
| Miriam Halperin Wernli | | |
7 of 7
|
| |
N/A
|
| |
N/A
|
|
| Stephen Hurst | | |
6 of 6(1)
|
| |
N/A
|
| |
N/A
|
|
| Bruce Linton | | |
7 of 7
|
| |
3 of 3
|
| |
9 of 9
|
|
| Perry Dellelce | | |
7 of 7
|
| |
3 of 3
|
| |
9 of 9
|
|
| Brigid Makes | | |
7 of 7
|
| |
3 of 3
|
| |
9 of 9
|
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Non-Equity Incentive
Plan Compensation ($) |
| | | | | | | | | | | | | | | | | | | |||||||||
|
Name and Principal Position
|
| |
Year(1)
|
| |
Salary
(C$) |
| |
Consulting
Fees (C$) |
| |
Share-
Based Awards (C$)(2) |
| |
Option-
Based Awards (C$) |
| |
Annual
Incentive Plans |
| |
Long-
Term Incentive Plan |
| |
Pension
Value (C$) |
| |
All Other
Compensation (C$) |
| |
Total
Compensation (C$) |
| ||||||||||||||||||||||||||||||
|
Jamon Alexander Rahn
Chief Executive Officer(3)(4) |
| | | | 2020 | | | | | | 266,667 | | | | | | 130,188 | | | | | | Nil | | | | | | 1,038,578 | | | | | | 175,000 | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | 1,610,433 | | |
| | | 2019 | | | | | | Nil | | | | | | 94,436 | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | 94,436 | | | |||
|
Stephen Hurst
Former Co-Chief Executive Officer(3)(5) |
| | | | 2020 | | | | | | 266,667 | | | | | | 190,000 | | | | | | Nil | | | | | | Nil | | | | | | 80,000 | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | 536,667 | | |
| | | 2019 | | | | | | Nil | | | | | | 132,040 | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | 132,040 | | | |||
|
David Guebert
Chief Financial Officer(6) |
| | | | 2020 | | | | | | 55,479 | | | | | | 122,380 | | | | | | Nil | | | | | | 266,859 | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | 444,718 | | |
| | | 2019 | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | — | | | |||
|
Paul Van Damme
Former Chief Financial Officer(7) |
| | | | 2020 | | | | | | Nil | | | | | | 43,070 | | | | | | Nil | | | | | | 20,772 | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | 63,842 | | |
| | | 2019 | | | | | | Nil | | | | | | 22,744 | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | 22,744 | | | |||
|
Scott Freeman
Former President and Chief Medical Officer(8) |
| | | | 2020 | | | | | | 260,003 | | | | | | 40,000 | | | | | | Nil | | | | | | 207,720 | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | 507,723 | | |
| | | 2019 | | | | | | Nil | | | | | | 67,604 | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | 67,604 | | | |||
|
Carol Nast
Chief Operating Officer(9) |
| | | | 2020 | | | | | | 266,667 | | | | | | 35,750 | | | | | | Nil | | | | | | 324,556 | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | 626,973 | | |
| | | 2019 | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | — | | | |||
|
Miri Halperin Wernli(11)
President |
| | | | 2020 | | | | | | 106,695 | | | | | | 28,201 | | | | | | Nil | | | | | | 1,014,439 | | | | | | 80,641 | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | 1,229,976 | | |
| | | 2019 | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | — | | | |||
|
Duane Parnham
Former Chief Executive Officer(11) |
| | | | 2019 | | | | | | Nil | | | | | | 100,000 | | | | | | Nil | | | | | | 10,000(12) | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | 110,000(13) | | |
| | | 2018 | | | | | | Nil | | | | | | 60,000 | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | 60,000 | | | |||
|
Suzanne Wood
Former Chief Financial Officer and Director(14) |
| | | | 2019 | | | | | | Nil | | | | | | 10,000(15) | | | | | | Nil | | | | | | 10,000(12) | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | 20,000 | | |
| | | 2018 | | | | | | Nil | | | | | | 90,000 | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | 90,000 | | | |||
|
Eric Myung
Former Chief Financial Officer(16) |
| | | | 2019 | | | | | | Nil | | | | | | 31,180(16) | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | 31,180 | | |
| | | 2018 | | | | | | Nil | | | | | | 90,000(17) | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | | 90,000 | | |
|
Name
|
| |
Number of
securities underlying unexercised options (#) |
| |
Option
exercise price (C$) |
| |
Option
expiration date |
| |
Value of
unexercised in-the-money options ($) |
| |
Number of
shares or units of shares that have not vested (#) |
| |
Market or
payout value of share-based awards that have not vested ($) |
| |
Market or
payout value of vested share-based awards not paid out or distributed ($) |
| |||||||||||||||||||||
| Jamon Alexander Rahn | | | | | 3,750,000 | | | | | $ | 0.33 | | | | | | 2025-02-27 | | | | | | 10,459,224 | | | | | | nil | | | | | | nil | | | | | | nil | | |
| Stephen Hurst | | | | | nil | | | | | | n/a | | | | | | n/a | | | | | | n/a | | | | | | nil | | | | | | nil | | | | | | nil | | |
| David Guebert | | | | | 900,000 | | | | | $ | 0.45 | | | | | | 2025-09-09 | | | | | | 2,425,361 | | | | | | nil | | | | | | nil | | | | | | nil | | |
| Paul Van Damme | | | | | 100,000 | | | | | $ | 0.33 | | | | | | 2021-02-27 | | | | | | 278,913 | | | | | | nil | | | | | | nil | | | | | | nil | | |
| Scott Freeman | | | | | 1,000,000 | | | | | $ | 0.33 | | | | | | 2021-02-27 | | | | | | 2,789,126 | | | | | | nil | | | | | | nil | | | | | | nil | | |
| Carol Nast | | | | | 1,204,427 | | | | | $ | 0.33 | | | | | | 2025-02-27 | | | | | | 3,359,299 | | | | | | nil | | | | | | nil | | | | | | nil | | |
| Miri Halperin Wernli | | | | | 1,200,000 | | | | | $ | 0.33 | | | | | | 2025-02-27 | | | | | | 3,346,952 | | | | | | nil | | | | | | nil | | | | | | nil | | |
| | | | | | 2,250,000 | | | | | $ | 0.43 | | | | | | 2025-07-15 | | | | | | 6,098,759 | | | | | | | | | | | | | | | | | | | | |
|
Name
|
| |
Option-based
awards-Value vested during the year ($) |
| |
Share-based
awards-Value vested during the year ($) |
| |
Non-equity
incentive plan compensation- Value earned during the year ($) |
| |||||||||
| Jamon Alexander Rahn | | | | | 259,625 | | | | | | nil | | | | | | 175,000 | | |
| Stephen Hurst | | | | | nil | | | | | | nil | | | | | | 80,000 | | |
| David Guebert | | | | | nil | | | | | | nil | | | | | | nil | | |
| Paul Van Damme | | | | | 20,770 | | | | | | nil | | | | | | nil | | |
| Scott Freeman | | | | | nil | | | | | | nil | | | | | | nil | | |
| Carol Nast | | | | | 74,372 | | | | | | nil | | | | | | nil | | |
| Donald Gehlert | | | | | nil | | | | | | nil | | | | | | nil | | |
| Miri Halperin Wernli | | | | | 38,078 | | | | | | nil | | | | | | 80,641 | | |
|
Name(1)
|
| |
Fees
Earned ($) |
| |
Share-
Based Awards ($) |
| |
Option-
Based Awards ($) |
| |
Non-Equity
Incentive Plan Compensation ($) |
| |
Pension
Value ($) |
| |
All Other
Compensation ($) |
| |
Total
($) |
| |||||||||||||||||||||
| Bruce Linton | | | | | Nil | | | | | $ | 248,974(2) | | | | | $ | 41,543 | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | $ | 289,517 | | |
| Perry Dellelce | | | | | Nil | | | | | | Nil | | | | | $ | 31,157 | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | $ | 31,157 | | |
| Brigid Makes | | | | | Nil | | | | | | Nil | | | | | $ | 41,543 | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | $ | 41,543 | | |
| Stanley Glick(3) | | | | | Nil | | | | | | Nil | | | | | $ | 31,157 | | | | | | Nil | | | | | | Nil | | | | | | Nil | | | | | $ | 31,157 | | |
| | | |
Option-based Awards
|
| |
Share-based Awards
|
| ||||||||||||||||||||||||||||||||||||
|
Name
|
| |
Number of
securities underlying unexercised options (#) |
| |
Option
exercise price (C$) |
| |
Option
expiration date |
| |
Value of
unexercised in-the-money options ($) |
| |
Number of
shares or units of shares that have not vested (#) |
| |
Market or
payout value of share-based awards that have not vested ($) |
| |
Market or
payout value of vested share-based awards not paid out or distributed ($) |
| |||||||||||||||||||||
| Bruce Linton | | | | | 200,000 | | | | | $ | 0.33 | | | | | | 2025-02-27 | | | | | | 557,825 | | | | | | Nil | | | | | | nil | | | | | | nil | | |
| Perry Dellelce | | | | | 150,000 | | | | | $ | 0.33 | | | | | | 2025-02-27 | | | | | | 418,369 | | | | | | Nil | | | | | | nil | | | | | | nil | | |
| Brigid Makes | | | | | 200,000 | | | | | $ | 0.33 | | | | | | 2025-02-27 | | | | | | 557,825 | | | | | | Nil | | | | | | nil | | | | | | nil | | |
| Stanley Glick | | | | | 150,000 | | | | | $ | 0.33 | | | | | | 2025-02-27 | | | | | | 418,369 | | | | | | Nil | | | | | | nil | | | | | | nil | | |
|
Name
|
| |
Option-based
awards — Value vested during the year ($) |
| |
Share-based
awards — Value vested during the year ($) |
| |
Non-equity incentive plan
compensation — Value earned during the year ($) |
| |||||||||
| Bruce Linton | | | | | nil | | | | | | nil | | | | | | nil | | |
| Perry Dellelce | | | | | nil | | | | | | nil | | | | | | nil | | |
| Brigid Makes | | | | | nil | | | | | | nil | | | | | | nil | | |
| Stanley Glick | | | | | nil | | | | | | nil | | | | | | nil | | |
|
Plan Category
|
| | | | |
Number of
securities to be issued upon exercise of outstanding options, warrants and rights |
| |
Weighted-
average exercise price of outstanding options, warrants and rights |
| |
Number of
securities remaining available for future issuance under equity compensation plans (excluding securities reflected in first column) |
| |||||||||
|
Equity compensation plans approved by securityholders
|
| |
Option Plan
|
| | | | 22,592,497 | | | | | $ | 0.38 | | | | | | 13,699,613(1) | | |
|
PR Plan
|
| | | | Nil | | | | | | Nil | | | | | | 13,699,613(1) | | | |||
|
Equity compensation plans not approved by securityholders
|
| | | | | | | Nil | | | | | | Nil | | | | | | Nil | | |
|
Total
|
| | | | | | | 22,592,497 | | | | | $ | 0.38 | | | | | | 13,699,613 | | |
|
PART 1
INTERPRETATION |
| ||||||
| | | | | A-8 | | | |
| | | | | A-8 | | | |
|
PART 2
SHARES AND SHARE CERTIFICATES |
| ||||||
| | | | | A-8 | | | |
| | | | | A-8 | | | |
| | | | | A-9 | | | |
| | | | | A-9 | | | |
| | | | | A-9 | | | |
| | | | | A-9 | | | |
| | | | | A-9 | | | |
| | | | | A-9 | | | |
| | | | | A-9 | | | |
| | | | | A-10 | | | |
|
PART 3
ISSUE OF SHARES |
| ||||||
| | | | | A-10 | | | |
| | | | | A-10 | | | |
| | | | | A-10 | | | |
| | | | | A-10 | | | |
| | | | | A-10 | | | |
|
PART 4
SHARE REGISTERS |
| ||||||
| | | | | A-10 | | | |
| | | | | A-10 | | | |
| | | | | A-11 | | | |
|
PART 5
SHARE TRANSFERS |
| ||||||
| | | | | A-11 | | | |
| | | | | A-11 | | | |
| | | | | A-11 | | | |
| | | | | A-11 | | | |
| | | | | A-11 | | | |
| | | | | A-12 | | | |
| | | | | A-12 | | | |
|
PART 6
TRANSMISSION OF SHARES |
| ||||||
| | | | | A-12 | | | |
| | | | | A-12 | | | |
|
PART 7
ACQUISITION OF COMPANY’S SHARES |
| ||||||
| | | | | A-12 | | | |
| | | | | A-12 | | | |
| | | | | A-12 | | |
|
PART 8
BORROWING POWERS |
| ||||||
| | | | | A-13 | | | |
| | | | | A-13 | | | |
|
PART 9
ALTERATIONS |
| ||||||
| | | | | A-13 | | | |
| | | | | A-14 | | | |
| | | | | A-14 | | | |
| | | | | A-14 | | | |
| | | | | A-14 | | | |
|
PART 10
MEETINGS OF SHAREHOLDERS |
| ||||||
| | | | | A-14 | | | |
| | | | | A-14 | | | |
| | | | | A-14 | | | |
| | | | | A-14 | | | |
| | | | | A-15 | | | |
| | | | | A-15 | | | |
| | | | | A-15 | | | |
| | | | | A-15 | | | |
| | | | | A-15 | | | |
|
PART 11
PROCEEDINGS AT MEETINGS OF SHAREHOLDERS |
| ||||||
| | | | | A-18 | | | |
| | | | | A-18 | | | |
| | | | | A-18 | | | |
| | | | | A-18 | | | |
| | | | | A-18 | | | |
| | | | | A-19 | | | |
| | | | | A-19 | | | |
| | | | | A-19 | | | |
| | | | | A-19 | | | |
| | | | | A-19 | | | |
| | | | | A-19 | | | |
| | | | | A-19 | | | |
| | | | | A-19 | | | |
| | | | | A-19 | | | |
| | | | | A-20 | | | |
| | | | | A-20 | | | |
| | | | | A-20 | | | |
| | | | | A-20 | | | |
| | | | | A-20 | | | |
| | | | | A-20 | | | |
| | | | | A-20 | | | |
| | | | | A-20 | | | |
| | | | | A-20 | | |
|
PART 12
VOTES OF SHAREHOLDERS |
| ||||||
| | | | | A-20 | | | |
| | | | | A-21 | | | |
| | | | | A-21 | | | |
| | | | | A-21 | | | |
| | | | | A-21 | | | |
| | | | | A-21 | | | |
| | | | | A-21 | | | |
| | | | | A-22 | | | |
| | | | | A-22 | | | |
| | | | | A-22 | | | |
| | | | | A-22 | | | |
| | | | | A-22 | | | |
| | | | | A-22 | | | |
| | | | | A-23 | | | |
| | | | | A-23 | | | |
| | | | | A-23 | | | |
|
PART 13
DIRECTORS |
| ||||||
| | | | | A-23 | | | |
| | | | | A-23 | | | |
| | | | | A-23 | | | |
| | | | | A-24 | | | |
| | | | | A-24 | | | |
| | | | | A-24 | | | |
| | | | | A-24 | | | |
| | | | | A-24 | | | |
|
PART 14
ELECTION AND REMOVAL OF DIRECTORS |
| ||||||
| | | | | A-24 | | | |
| | | | | A-24 | | | |
| | | | | A-24 | | | |
| | | | | A-25 | | | |
| | | | | A-25 | | | |
| | | | | A-25 | | | |
| | | | | A-25 | | | |
| | | | | A-25 | | | |
| | | | | A-25 | | | |
| | | | | A-25 | | | |
| | | | | A-25 | | | |
|
PART 15
ALTERNATE DIRECTORS |
| ||||||
| | | | | A-26 | | | |
| | | | | A-26 | | | |
| | | | | A-26 | | | |
| | | | | A-26 | | | |
| | | | | A-26 | | |
| | | | | A-26 | | | |
| | | | | A-26 | | | |
| | | | | A-27 | | | |
|
PART 16
POWERS AND DUTIES OF DIRECTORS |
| ||||||
| | | | | A-27 | | | |
| | | | | A-27 | | | |
|
PART 17
INTERESTS OF DIRECTORS AND OFFICERS |
| ||||||
| | | | | A-27 | | | |
| | | | | A-27 | | | |
| | | | | A-27 | | | |
| | | | | A-27 | | | |
| | | | | A-27 | | | |
| | | | | A-28 | | | |
| | | | | A-28 | | | |
| | | | | A-28 | | | |
|
PART 18
PROCEEDINGS OF DIRECTORS |
| ||||||
| | | | | A-28 | | | |
| | | | | A-28 | | | |
| | | | | A-28 | | | |
| | | | | A-28 | | | |
| | | | | A-29 | | | |
| | | | | A-29 | | | |
| | | | | A-29 | | | |
| | | | | A-29 | | | |
| | | | | A-29 | | | |
| | | | | A-29 | | | |
| | | | | A-29 | | | |
| | | | | A-29 | | | |
|
PART 19
BOARD COMMITTEES |
| ||||||
| | | | | A-30 | | | |
| | | | | A-30 | | | |
| | | | | A-30 | | | |
| | | | | A-30 | | | |
|
PART 20
OFFICERS |
| ||||||
| | | | | A-31 | | | |
| | | | | A-31 | | | |
| | | | | A-31 | | | |
| | | | | A-31 | | | |
|
PART 21
INDEMNIFICATION |
| ||||||
| | | | | A-31 | | | |
| | | | | A-31 | | | |
| | | | | A-31 | | | |
| | | | | A-32 | | |
| | | | | A-32 | | | |
| | | | | A-32 | | | |
|
PART 22
DIVIDENDS |
| ||||||
| | | | | A-32 | | | |
| | | | | A-32 | | | |
| | | | | A-32 | | | |
| | | | | A-32 | | | |
| | | | | A-32 | | | |
| | | | | A-32 | | | |
| | | | | A-33 | | | |
| | | | | A-33 | | | |
| | | | | A-33 | | | |
| | | | | A-33 | | | |
| | | | | A-33 | | | |
| | | | | A-33 | | | |
| | | | | A-33 | | | |
| | | | | A-33 | | | |
|
PART 23
ACCOUNTING RECORDS AND AUDITOR |
| ||||||
| | | | | A-33 | | | |
| | | | | A-34 | | | |
| | | | | A-34 | | | |
|
PART 24
NOTICES |
| ||||||
| | | | | A-34 | | | |
| | | | | A-34 | | | |
| | | | | A-35 | | | |
| | | | | A-35 | | | |
| | | | | A-35 | | | |
| | | | | A-35 | | | |
|
PART 25
SEAL |
| ||||||
| | | | | A-35 | | | |
| | | | | A-35 | | | |
| | | | | A-35 | | | |
|
PART 26
PROHIBITIONS |
| ||||||
| | | | | A-36 | | | |
| | | | | A-36 | | | |
| | | | | A-36 | | | |
|
PART 27
SUBORDINATE VOTING SHARES |
| ||||||
| | | | | A-36 | | | |
|
PART 28
MULTIPLE VOTING SHARES |
| ||||||
| | | | | A-36 | | |
| 1. Title and Conflict | | | All Award PSUs and Award RSUs issued under the Plan to U.S. Participants are intended to be exempt from and avoid the penalties imposed by Section 409A, or any successor thereto, and all provisions hereunder shall be read, interpreted, and applied with that purpose in mind. The provisions of the Award Agreement applicable to any U.S. Participant may be revised to addressshall reflect this intention. | |
| 2. Definitions | | | ||
| “Change in Control” | | | “Change in Control” means a transaction described in Section 1.3.9 of the Plan, but only to the extent that such a transaction constitutes a “change in the ownership of a corporation, a change in the effective control of the Corporationa corporation, or a change in the ownership of a substantial portion of thea corporation’s assets of the Corporation, as defined in regulationU.S. Treasury Regulation Section 1.409A-3(i)(5) under Section 409A. | |
| “Market Value” | | | “Market Value” shall have the meaning as to U.S. Participants as specified in Section 1.3.14 of the Plan. | |
| “Section 409A” | | | “Section 409A” means section 409A of the U.S. Tax Code. | |
| “Separation from Service” | | | “Separation from Service” means a “separation from service” for purposes of Section 409A(a)(2)(A)(i) of the U.S. Tax Code. | |
| “Specified Employee” | | | “Specified Employee” means a “specified employee” as determined in a manner that complies with Section 409A(2)(B)(i) of the U.S. Tax Code. | |
| “U.S. Tax Code” | | | “U.S. Tax Code” means the United States Internal Revenue Code of 1986, as amended, and the regulations and guidance issued under it from time to time. | |
| 3. Payment | | | The Award Agreement shall state the Vesting Date. It is intended that the vesting conditions for the Awardaward shall constitute a “substantial risk of forfeiture” within the meaning of Section 409A and that PSUs and RSUs will be exempt from Section 409A under U.S. Treasury Regulation section 1.409A-1(b)(4). Sections 7.4 and 7.5 and all other provisionprovisions of the Plan shall be interpreted and administered such that RSUs and PSUs will be settled and paid out by March 15th of the calendar year following the calendar year in which such RSUs and PSUs are not, or are no longer, subject to a substantial risk of forfeiture. Further, for greater certainty, where a U.S. Participant experiences a Period of Absence as described in Section 7.6.4 of the Plan, PSUs and RSUs will be subject to forfeiture until the date that the U.S. Participant returns to active full-time employment within 180 days following the end of the Performance Period, or the Vesting Date for RSUs, as applicable. | |
| | | | However, to the extent that any PSU or RSU awarded would constitute “non-qualified deferred compensation” that is subject to Section 409A, then the following terms shall apply to such award: | |
| | | | Notwithstanding Sections 7.4 or 7.5 to the contrary, payment of Vested PSUs or Vested RSUs shall be made to the U.S. Participant or his legal representative, as applicable, in a single lump sum, less any applicable statutory withholdings or deductions, either (1) between January 1 and March 15, if the last day of the Performance Period or the Vesting Date, as applicable, is December 31, or (2) if (1) does not apply, no later than 75 daysduring the calendar year immediately following the last day ofcalendar year in which the Performance Period ends or the Vesting Date, as applicable occurs (or, in the event of the Participant’s death, no later than 75 dayspayment of Vested RSUs shall be made in the calendar year following the datecalendar year of the Participant’s death), provided that the Participant does not have a right to designate the year of the payment. Neither the Board, the Corporation nor its directors, officers or employees make any representations or warranties regarding the tax treatment of any payments under the Plan and none of them shall be held liable for any taxes, interest, penalties or other monetary amounts owed by a U.S. Participant as a result of the application of Section 409A. Notwithstanding any contrary provision set forth in the Plan (and, in particular, in Section 7 of the Plan) , the payment of any amounts due under the Plan subject to Section 409A shall be made in compliance with Section 409A and shall not be accelerated except as otherwise permitted under Section 409A. Where applicable to avoid violation of Section 409A, any reference to or requirement relating to the termination or cessation of a U.S. Participant’s employment mayshall instead refer to or require such U.S. Participant’s Separation from Service. If required for Award PSUs or Award RSUs subject to Section 409A, if any Award Agreement requires payment upon Separation from Service, then a Specified Employee’s payment shall be delayed until a date that is six months following the date of the U.S. Participant’s Separation from service (or, if earlier, the date of death of the U.S. Participant). | |
| 4. Change in Control | | | Section 7.8 of the Plan (“Change in Control”) shall apply to Award PSUs and Award RSUs that constitute deferred compensation under Section 409A held by a U.S. Participant only if the Change in Control constitutes a Change in Control of the Corporation as defined in this Addendum. With respect to a transaction that constitutes a Change in Control under Section 7.8 of the Plan but does not constitute a Change in Control as defined in this Addendum, to the extent so provided by the Plan, unless otherwise determined not to become vested by the Board, all unvested PSUs and RSUs shall become fully vested (shall become Vested PSUs and Vested RSUs), but the payment of such rights shall be in the Award Agreement. | |